Hemab Therapeutics Holdings, Inc. (COAG): SCHEDULE 13G filed Aug 7, 2026

Name: Hemab Therapeutics Holdings, Inc. SCHEDULE 13G (0002005369-26-000041)
Creator: Hemab Therapeutics Holdings, Inc.
Published: 2026-08-07

Form type: SCHEDULE 13G
Filing date: Aug 7, 2026
Accession number: 0002005369-26-000041
Filer: Hemab Therapeutics Holdings, Inc. (CIK 2114044)